{"database": "openregs", "table": "dockets", "rows": [["FDA-2026-N-3500", "FDA", "Notice of Approval of Product Under Priority Review Voucher; Material Threat Medical Countermeasure Priority Review Voucher; MRESVIA (Respiratory Syncytial Virus Vaccine)", "Nonrulemaking", "2026-04-16T13:07:20Z", "0b000064b92495be"]], "columns": ["id", "agency_id", "title", "docket_type", "last_modified", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2026-N-3500"], "units": {}, "query_ms": 6.060843821614981, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}